[Progress on in situ cell transdifferentiation in central nervous system].

Area of Science:

• Neuroscience
• Regenerative Medicine
• Cell Biology

Background:

• Central nervous system (CNS) injuries cause irreversible neuronal loss and glial scar formation, leading to lasting neurological deficits.
• Current regenerative medicine strategies focus on replacing lost neurons to repair CNS damage.

Purpose of the Study:

• To review the progress of in situ transdifferentiation of glial cells into functional neurons within the CNS.
• To explore the potential of glial cell reprogramming for treating neuronal injury and neurodegenerative diseases.

Main Methods:

• Literature review of current research on in situ transdifferentiation in the CNS.
• Focus on glial cell types, their characteristics, and reprogramming advancements.

Main Results:

• Mature glial cells can be reprogrammed into functional neurons.
• In situ transdifferentiation of endogenous glia presents a unique advantage for CNS repair.

Conclusions:

• Glial cell reprogramming offers a viable therapeutic strategy for neuronal damage.
• Further research provides a theoretical basis for clinical applications in treating neurological disorders.